Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Potential New Method of Pancreaticojejunostomy

By HospiMedica staff writers
Posted on 02 Apr 2008
A new method of pancreaticojejunostomy using a fast-absorbable suture material and a temporary stent tube could overcome the technical difficulties involved in performing a pancreaticoenterostomy of a soft pancreas with a narrow pancreatic duct.

Researchers from Hirosaki University (Aomori, Japan) examined 63 consecutive patients with soft pancreas undergoing a pancreaticoduodenectomy between 2003 and 2006. More...
Thirty-five of these patients were treated with a new reconstructive method, and the initial surgical results were retrospectively compared with those of the 28 patients treated with conventional duct-to-mucosa anastomosis. After the pancreatic transaction, a stent tube was inserted into the lumen of the pancreatic duct and ligated to it by a fast-absorbable irradiated polyglactin 910 suture. Another tip of the stent tube was introduced into the intestinal lumen at the jejunal limb, where a purse-string suture was made by another fast-absorbable suture to roughly fix the tube. The pancreaticojejunostomy was completed by ligating two fast-absorbable sutures to approximate the ductal end and the jejunal mucosa, and by adding a rough anastomosis between the pancreatic parenchyma and the seromuscular layer of the jejunum.

The initial surgical results showed that incidences of postoperative morbidity, including pancreatic fistula, were comparable between the two groups. There was no mortality and re-admission, and late complications were rarely seen. Using the new technique, complete external drainage of the pancreatic juice was secured for about 2 weeks by approximating the pancreatic duct and the jejunal mucosa with the fast-absorbable suture. The researchers claimed that the good early and late outcomes of the simple and easy-to-perform method seem to justify the carrying out of a randomized prospective study to compare it with appropriate controls. The study was published in the February 21, 2008, issue of the World Journal of Gastroenterology.

"A pancreaticojejunostomy using an irradiated polyglactin 910 suture material and a temporary stent is easy to perform and is feasible even in cases with a narrow pancreatic duct and a normal soft pancreas,” concluded lead author Dr. Kenichi Hakamada, M.D., and colleagues of the department of gastroenterological surgery.

Leakage of the pancreaticoenterostomy remains a major cause of postoperative morbidity and mortality after pancreaticoduodenectomy. Many factors have been identified that are associated with an increased incidence of this complication. Among them, a soft pancreatic texture with a narrow pancreatic ductal size creates a high risk for the development of a pancreatic fistula, often leading to death.


Related Links:
Hirosaki University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.